Skip to main content
. Author manuscript; available in PMC: 2016 Dec 15.
Published in final edited form as: J Thorac Oncol. 2015 Sep;10(9):e86–e88. doi: 10.1097/JTO.0000000000000571

Figure 1.

Figure 1

(A) CT-guided biopsy of the lung lesion at the time of diagnosis. (B) CT chest before erlotinib administration. (C) CT chest three months after erlotinib initiated. (D) CT-guided biopsy of the lung cancer at the time of progression on erlotinib.